Self-Supervised Constraint-Induced Movement Therapy for Stroke Recovery
Official title: A Novel Approach to Implementing Constraint-Induced Movement Therapy in Stroke Rehabilitation
Run by Ohio State University · NCT07723300 · Data updated 2026-11-12
This study tests a partly self-guided therapy program to help adults recover the use of their weaker arm after stroke, aiming to require less time with a therapist.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 85 Years |
| Sex | All |
| Enrollment | 12 (estimated) |
| Sponsor | Ohio State University Academic / other |
| Locations | 1 site (Columbus, Ohio) |
| Status | Recruiting |
| Started | July 29, 2026 |
| Main results expected | December 2027 |
| Study ends | December 2027 |
| Registry record updated | August 25, 2026 |
| Trial ID | NCT07723300 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–85 who recently had a first-time ischemic or hemorrhagic stroke and have moderate upper-extremity weakness, ability to extend the wrist, and can follow simple instructions.
✕Probably not a fit
Individuals with severe pain, high spasticity, or inability to meet basic movement or cognitive requirements may not benefit from this approach.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study evaluates a partially self-supervised constraint-induced movement therapy (sCIMT) approach for adults with arm and hand weakness after stroke. Participants will perform a therapy routine five days a week for two weeks, with a mitt worn on the stronger hand during selected activities to encourage use of the affected limb. The study will assess functional use of the affected arm, participant-perceived usefulness and feasibility, and impact on quality of life. Outcomes include objective motor assessments and self-reported measures collected before and after the program. The trial is led by Ohio State University in Columbus, with no listed collaborators beyond the lead sponsor.
Why it matters
Potential benefit: If successful, participants may gain better use of their weaker arm and improved daily functioning with a shorter therapist-assisted commitment.
How similar studies have gone: Prior CIMT approaches have shown functional gains after stroke; this study tests a partially self-supervised format to reduce therapist contact.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Sustained a first-time ischemic or hemorrhagic stroke ≥2 weeks prior to study enrollment * Age ≥18 and ≤85 * Moderate UE hemiparesis as defined by a score ≥13 and ≤47 on the modified UE section of the Fugl-Meyer Assessment (60-point scale with no reflex testing) * Ability to actively extend impaired wrist ≥10 degrees * UE strength and active range of motion within functional limits on the non-hemiparetic side * Ability to follow two-step commands (visual or verbal) as determined by the clinical investigator * Nonuse of the more impaired UE as evidenced by an average score ≤2.5 on the Motor Activity Log Amount of Use Scale. Exclusion Criteria: * Excessive pain in the affected shoulder, arm, or hand as measured by a score ≥6 on a 10-point visual analogue scale * Unable to passively reach neutral position for wrist extension and forearm supination * Excessive spasticity in the affected wrist or finger flexors/extensors and elbow flexors, as defined as a score of \>2 on the Modified Ashworth Scale (MAS) * Inability to actively participate in regular therapy sessions (e.g., due to medical complexity, insufficient endurance, transportation, etc.) as determined by participant or by clinical judgement of the evaluating therapist * Receiving occupational therapy services for the hemiparetic UE during the two-week intervention window (including after pre-assessment and before post-assessment) * Received focal anti-spasticity drug injection (e.g., Botox) to any muscles of the impaired UE within the past 1 month (or plan to at some point during study enrollment) * Comorbid diagnosis in addition to stroke (e.g., dementia, peripheral neuropathy) that in the opinion of the investigator could impact study results * Presence of moderate to severe unilateral spatial neglect as indicated by clinical observation or failure on a standardized screening tool (e.g., Line Bisection Test or Bells Test).
Where it's running
-
Ohio State University
Columbus, Ohio, United States Recruiting
Study contacts
- Study coordinator: Peyton Miller
- Email: peyton.miller@osumc.edu
- Phone: 380-283-5825
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using IMPROVE to guide carotid revascularisation decisions
This trial tests whether using the IMPROVE MRI-based score to select patients for carotid revascularisation is as good as standard care based mainly on stenosis degree, among people who have had a recent stroke or TIA due to carotid disease.
-
Deep phenotyping to explore recovery in young adults after stroke
This project will test whether a detailed health and sample-collection approach (deep phenotyping) is practical and acceptable for people aged 18–55 who have had a stroke.
-
Stem cell therapy for chronic stroke recovery
This study is testing whether using a patient's own stem cells can help people with long-term stroke recovery feel better and improve their daily functioning.
-
Emergency Stroke Unit for treating acute strokes
This study is testing a new Emergency Stroke Unit that uses a mobile MRI to see if it can help treat stroke patients faster and improve their recovery.
-
Telehealth program for lifestyle changes in stroke survivors
This study tests whether a telehealth program can help stroke survivors make healthy lifestyle changes with support from others over six months.
-
A digital tool for assessing cognitive impairment in stroke survivors
This study is testing a new digital tool that helps stroke survivors check for thinking and memory problems on their own to improve their care after a stroke.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.